Atlas Trials

Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder

Clinical trial NCT06701903 · RECRUITING

Trial details

NCT number
NCT06701903
Sponsor
Intra-Cellular Therapies, Inc.
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Generalized Anxiety Disorder
Start date
2024-11-21
Primary completion
2027-10-14
Enrollment
570

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.